Drivers of Unit Cost Variation in Voluntary Medical Male Circumcision in Sub-Saharan Africa: A meta-regression analysis Drew Cameron UC Berkeley IAEN.

Slides:



Advertisements
Similar presentations
Towards Shared Patient Data: Harmonization of District Health Information System Data for Nationwide Reporting Towards Shared Patient Data: Harmonization.
Advertisements

ASSESSING RISK COMPENSATION POST-VOLUNTARY MEDICAL MALE CIRCUMCISION IN ZAMBIA Paul C. Hewett a, Petra Todd b, Nicolas Grau c, Erica Soler- Hampejsek c,
Jhpiego Male Circumcision Programs Jabbin Mulwanda Kelly Curran Technical Leadership Office 19 May 2009.
Evidence Review: What Do We Know about the Needs of Adolescent Voluntary Medical Male Circumcision Clients? July 2014 Lynn M. Van Lith, MPA Johns Hopkins.
Scaling up voluntary medical male circumcision Catherine Hankins MD MSc FRCPC Chief Scientific Adviser to UNAIDS Office of the Deputy Executive Director,
Assessing technical efficiency of HIV prevention interventions in three sub-Saharan countries S Bautista-Arredondo, SG Sosa-Rubí, D Contreras-Loya, M Opuni,
Assessment of PEPFAR’s Impact on Selected Health System Parameters in Sub-Saharan African Countries Presented by: Anya Shen Viviane D. Lima, Wendy Zhang,
Moving to the final chapter of the AIDS epidemic.
Center for Global Health Division of Global HIV/AIDS John Pitman Division of Global HIV/AIDS, Center for Global Health, CDC.
ADAPT Update AfriCan Forum Entebbe, January 2013.
Office of Global Health and HIV (OGHH) Office of Overseas Programming & Training Support (OPATS) Session: Voluntary Medical Male Circumcision (VMMC)
PEPFAR Investment Strategy (8 years of PEPFAR) Data source : OGAC Budget Total PEPFAR Investment: $21,285,918,291 Saving Lives : Changing the.
Urbanization, Wealth and Overweight in Sub- Saharan Africa Nyovani Madise & Gobopamang Letamo* *University of Botswana 12 th June Population Health.
Differences in development. Three types of differences in development: local regional global.
AFRICA HIV/AIDS AIDS DATA SOURCE: UNAIDS 2007 REPORT WORLD HEALTH ORGANIZATION.
Costing Adult and Adolescent Male Circumcision in Kenya, Zambia, Zimbabwe and Uganda Urbanus Kioko (PHD) University of Nairobi Arusha, Tanzania 10 June.
Quality of Voluntary Medical Male Circumcision Services during Scale-Up: A Comparative Process Evaluation in Kenya, South Africa, Tanzania and Zimbabwe.
High-impact interventions. Number of people living with HIV who were not receiving antiretroviral therapy, 2014 and 2015 Source: UNAIDS estimates, 2014.
EngenderHealth’s Work on Male Circumcision
Getting more value for money: working with countries and partners toward greater effectiveness and efficiency Peter Stegman, Senior Economist.
ICAP Quarterly Master Slide Set July-September 2007.
Are Country Reputations for Good or Bad AIDS Leadership Deserved? An Exploratory Quantitative Analysis Nicoli Nattrass AIDS & Society Research Unit Centre.
HOW can HIV funding strengthen health systems Evidence from Malawi and Zambia Ruairí Brugha Royal College of Surgeons in Irelandand GHIN Network XV111International.
Modeling the Impact and Cost of Age and Regional Targeting for Voluntary Medical Male Circumcision Scale-up MOAC0203 and MOAC0204 Presented by Emmanuel.
Rwanda South Africa Burundi Uganda Ethiopia Cambodia Vietnam Lesotho Surinam Zimbabwe Zambia Kiribati Nepal Dr. Marie Charles Chair& CEO.
VMMC Sustainability and Early Infant Male Circumcision Dr. Tin Tin Sint HIV section, UNICEF New York.
LITERATURE REVIEW OF DECISION MODELS FOR DISEASES WITH SHORT-TERM FLUCTUATIONS/EPISODES: The Case of COPD Dr. Orpah Nasimiyu Wavomba
Voluntary Medical Male Circumcision: Introduction to the Cost, Impact, and Challenges of Accelerated Scaling Up International Conference on AIDS and Sexually.
Resource Availability for HIV, Overview of the financing situation
Somya Gupta, Reuben Granich
COST, IMPACT and CHALLENGES of ACCELERATED SCALE-UP
YouthPower Action funded and supported a special AIDS supplement entitled: Achieving 902: Young People, HIV Testing Services and Linkage to Treatment.
Jennifer Sherwood amfAR, The Foundation for AIDS Research
EISA ACE Southern Africa Regional Resource Centre
Urbanization, Wealth and Overweight in Sub-Saharan Africa
Interprofessional Online Learning for Primary Health Care:
Zimbabwe’s shift towards treat all: national country context
iHEA Boston 2017 Congress, Boston Massachusetts, USA 8-11 July 2017
Voluntary Male Medical Circumcision Case for Accelerated Scale Up
Ambassador Deborah L. Birx, MD
Supplementary Table 1. PRISMA checklist
Performance Measurement and Rural Primary Care: A scoping review
PEPFAR MC Supplies Meeting
Comparison of HIV self-testing (HIVST) costs in Zambia:
Sergio Bautista-Arredondo INSP
Africa Institute Initiatives on E Waste
“Social Protection Finance for a changing World of Work - Key Considerations For A Responsive Financing Framework For Social Protection In Africa ” Mutale.
Testing Efficiency Indicators
Willyanne DeCormier Plosky and Lori Bollinger July 20, 2018
Carl Fourie, Senior Programme Manager Pierre Dane,
Overview of importance and emerging innovations for testing and linkage CHERYL JOHNSON WORLD HEALTH ORGANIZATION HIV AND HEPATITIS DEPARTMENT 23 JULY.
Filling in the gaps: Extrapolations of VMMC unit costs and economies of scale using pool data from several studies. Carlos Pineda.
The Cost of Differentiated Service Delivery: A Systematic Review
Mauritius – Africa: DTAAs
Jepkoech Kottutt1, Emilia D. Rivadeneira2, Susan Hrapcak2
Reducing risk of male sex partners: HIV testing, treatment, and VMMC of men in PEPFAR-supported DREAMS districts Caroline Cooney1, Kimi Sato2, Shannon.
EMMANUEL NJEUHMELI, MD, MPH, MBA
Time for a quality revolution in global health
Forecasting the Cost of Financing ART in Sub-Saharan Africa under Differential Funding Scenarios Tahvi Frank and Austin Carter July 25, 2018.
Heterogeneity of Demographic and Risk Strata Across the UNAIDS Targets in Sub-Saharan Africa – A Systematic Review July 23rd, 2018.
Mapping HIV epidemics in sub-Saharan Africa with use of GPS data
Partnership for Male Circumcision: Achieving Scale
Pediatric HIV Case Finding Strategies
Voluntary Medical Male Circumcision (VMMC) Device Evaluations
Fifty Years of Economic Growth in Sub-Saharan Africa
survey prevalence (%) (year)
Progress on Voluntary Medical Male Circumcision for HIV prevention and How VMMC fits into UNAIDS ' ' target Julia Samuelson, Nurse epidemiologist.
2019 Progress Report launch
Factors associated with the high willingness to use Pre-exposure prophylaxis in female sex workers communities in Kampala, Uganda. Author: Dr. Bashir.
Health financing in Africa: Can we fill the gaps?
Presentation transcript:

Drivers of Unit Cost Variation in Voluntary Medical Male Circumcision in Sub-Saharan Africa: A meta-regression analysis Drew Cameron UC Berkeley IAEN pre-conference Amsterdam, Netherlands 20 July 2018

Overview Goal: Use published VMMC costing data to create a predictive model to extrapolate to settings where no data exists VMMC = Proof of Concept Search and Screening Extraction process Data preparation Exploration & analysis Limitations & next steps

PRISMA for published HIV studies Web of Science 2,682 Cochrane 810 PubMed 6,288 Embase 10,950 NHS EED 466 LILACS 163 Gray Lit & Google Scholar 2,399 Database Searching Total 21,539 Records identified 29 Records from other sources (Avenir, UCR, LSHTM, DCP3, snowball) 471 Unique Records (de-duped) 11,717 The following searches, validation, and snowball sampling activities were run between January 1 2016, and October 2, 2016. Records Excluded (non relevant topics, low yield hits) 9,199 HIV Articles Assessed for Eligibility 2,566 VMMC Studies Extracted 58 VMMC Studies Finally Included (modeled & duplicate data removed) 29

Data Extracted 58+ MC studies extracted (2016-7) VMMC Studies Extracted 58 VMMC Studies Included (modeled & duplicate data removed) 29 58+ MC studies extracted (2016-7) Early analysis & lessons learned Validated by analyst Quality assurance (early 2018) Removed 29 studies (29 total) Costs modeled or duplicative Insufficient reporting (gray lit)

Unit of observation Average unit cost of VMMC procedure (per patient) Country Studies Unit costs No. sites Botswana 1 2 Kenya 6 251 Lesotho 4 Mozambique Namibia 7 49 Rwanda +2 South Africa 11 31 Swaziland Tanzania 14 Uganda 5 10 65 Zambia 23 25 Zimbabwe 13 Total 29 89 503 Average unit cost of VMMC procedure (per patient) often average of multiple facilities per unit cost Weight by number of facilities per cost 2016 USD (WB GDP price deflator; exchange rates)

Geographic distribution of unit costs Figure 2. Heatmap of mean unit cost by country Country Mean unit cost Botswana $125.15 Kenya $44.79 Lesotho $64.50 Mozambique $32.31 Namibia $56.73 Rwanda $43.96 South Africa $107.68 Swaziland $61.79 Tanzania $69.25 Uganda $34.75 Zambia $70.06 Zimbabwe $61.71

Geographic distribution of unit costs Figure 2. Heatmap of mean unit cost by country Country Mean unit cost Botswana $125.15 Kenya $44.79 Lesotho $64.50 Mozambique $32.31 Namibia $56.73 Rwanda $43.96 South Africa $107.68 Swaziland $61.79 Tanzania $69.25 Uganda $34.75 Zambia $70.06 Zimbabwe $61.71

Data preparation Removed unit costs with poor reporting (n=48) No input costs reported (n=38) Personnel (direct service delivery; support) & traded goods (i.e. kits) not reported (n=10) 41 total unit costs remain with sufficient data

Unit cost variation by country

Analysis goals Review: Use published unit cost estimates to predict VMMC costs in countries/settings/years with no evidence Using mean and quantile regression Use variables that are good predictors of unit cost variation (extract: urbanicity, facility type, ownership) Additional data Per capita GDP by country-year (World Bank) Annual PEPFAR / Global Fund funding by country-year (IHME) MC coverage by country (Morris et al. 2016) HIV prevalence; ART coverage by country-year (World Bank)

Covariate missingness Facility Type Freq. Percent Clinic 3 7.3 Mixed (clinics & hospitals) 7 17.1 Hospitals 23 56.1 Mobile / community based 8 19.5 Ownership Freq. Percent Public 21 51.2 Mixed (public & private) 5 12.2 Private / NGO 15 36.6 Urbanicity Freq. Percent Urban / peri-urban 22 53.7 Mixed (urban & rural) 9 22.0 Rural 10 24.4

Covariate missingness Facility Type Freq. Percent Clinic 3 7.3 Mixed (clinics & hospitals) 7 17.1 Hospitals 23 56.1 Mobile / community based 8 19.5 Ownership Freq. Percent Public 21 51.2 Mixed (public & private) 5 12.2 Private / NGO 15 36.6 Urbanicity Freq. Percent Urban / peri-urban 22 53.7 Mixed (urban & rural) 9 22.0 Rural 10 24.4

Focus on cost inputs Focused on predictive models of key inputs (personnel, supplies, residuals) Start with predicting personnel costs

Model Selection Attempted multiple models, functional forms, specification tests, robustness checks OLS (log – log) Country fixed effects GLM Random & mixed effects models Quantile regression

GLM (link log; family gamma) VARIABLE (1) (2) (3) (4) (5) (6) (7) Key info   Year of data collection (2016 reference) -0.397 -1.003 0.264 -3.317*** -3.047*** -3.743*** -4.402*** GDP per capita (mean centered) 0.011 0.012** 0.008*** 0.009*** 0.000 -0.002 GDP per capita^2 (mean centered) -0.000 -0.000** -0.000*** 0.000** Urbanicity (urban omitted) Mixed -8.912*** 5.456*** 6.817** 5.605*** 6.513*** Rural 10.440* 5.107 2.839 2.483 2.531 Ownership (public omitted) -21.472*** -20.366*** -10.156*** -10.294*** Private / NGO -0.201 -0.061 19.981 14.648 Facility type (clinic omitted) -23.163 3.807 1.450 Hospital -20.692 2.168 -1.261 Mobile / community based -20.605 4.794 1.263 Health system HIV prevalence of pop (age 15-49) 122.640*** 77.945 MC coverage of men (all ages) -7.680 4.391 ART coverage of HIV+ pop (age 15-49) 31.928** 36.548** Donor engagement PEPFAR funding (per capita) -0.467 Global Fund funding (per capita) 0.949 BIC 1962.13 1962.69 1949.88 1924.07 1932.48 1937.52 1944.75 Observations 41 Standard errors in parentheses; *** p<0.01, ** p<0.05, * p<0.1

GLM (link log; family gamma) VARIABLE (1) (2) (3) (4) (5) (6) (7) Key info   Year of data collection (2016 reference) -0.397 -1.003 0.264 -3.317*** -3.047*** -3.743*** -4.402*** GDP per capita (mean centered) 0.011 0.012** 0.008*** 0.009*** 0.000 -0.002 GDP per capita^2 (mean centered) -0.000 -0.000** -0.000*** 0.000** Urbanicity (urban omitted) Mixed -8.912*** 5.456*** 6.817** 5.605*** 6.513*** Rural 10.440* 5.107 2.839 2.483 2.531 Ownership (public omitted) -21.472*** -20.366*** -10.156*** -10.294*** Private / NGO -0.201 -0.061 19.981 14.648 Facility type (clinic omitted) -23.163 3.807 1.450 Hospital -20.692 2.168 -1.261 Mobile / community based -20.605 4.794 1.263 Health system HIV prevalence of pop (age 15-49) 122.640*** 77.945 MC coverage of men (all ages) -7.680 4.391 ART coverage of HIV+ pop (age 15-49) 31.928** 36.548** Donor engagement PEPFAR funding (per capita) -0.467 Global Fund funding (per capita) 0.949 BIC 1962.13 1962.69 1949.88 1924.07 1932.48 1937.52 1944.75 Observations 41 Standard errors in parentheses; *** p<0.01, ** p<0.05, * p<0.1

Conclusions Pro Good scope of countries included Consistent relationships with GDP Per Capita Year Con VMMC = small sample size for analysis (n=41) Not enough good reporting of other characteristics Mean data masks variation in unit costs within countries/studies Extracted MC data alone insufficient for prediction